Fanconi anemia: young patients at high risk for squamous cell carcinoma

BACKGROUND: Fanconi anemia is one of the best studied inherited cancer-prone diseases. Greatly improved protocols for hematopoietic stem cell transplantation increasingly save the lives of these young patients. However, in both transplanted and not transplanted patients, the emergence of aggressive...

Descripción completa

Detalles Bibliográficos
Autores principales: Velleuer, Eunike, Dietrich, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530570/
https://www.ncbi.nlm.nih.gov/pubmed/26567103
http://dx.doi.org/10.1186/s40348-014-0009-8
Descripción
Sumario:BACKGROUND: Fanconi anemia is one of the best studied inherited cancer-prone diseases. Greatly improved protocols for hematopoietic stem cell transplantation increasingly save the lives of these young patients. However, in both transplanted and not transplanted patients, the emergence of aggressive squamous cell carcinoma represents a major medical challenge. CONCLUSIONS: This mini review summarizes current knowledge about the pathogenesis of squamous cell carcinoma (SCC) in the special context of Fanconi anemia.

Ejemplares similares